Skip to main content
Clinical Trials/ACTRN12622000908730
ACTRN12622000908730
Active, not recruiting
未知

Efficacy and neural mechanisms of computerised cognitive training in Huntington’s disease: A randomised controlled trial

Monash University0 sites30 target enrollmentJune 27, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Monash University
Enrollment
30
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 27, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria include:
  • (a) Genetically positive for Huntington’s disease (HD)
  • (b) Premanifest disease or early\-stage manifest disease (total functional capacity \[TFC] \= 7\-13\)
  • (c) 18\+ years of age
  • (d) Access to computer with Internet connection

Exclusion Criteria

  • Exclusion criteria include:
  • (a) Absence of known genetic confirmation for HD
  • (b) Late\-stage disease (TFC \< 7\)
  • (c) Under 18 years of age
  • (d) Diagnosis of any major neurological or psychiatric condition other than HD (besides anxiety or depression), history of substance abuse or head injury
  • (e) Severe depression and anxiety symptoms (score \> 14 on either HADS subscale)
  • (f) Unstable dose of medication for depression and anxiety in the last 6 months
  • Additional exclusion criteria if undergoing MRI:
  • (a) Left\-handed
  • (b) Currently pregnant

Outcomes

Primary Outcomes

Not specified

Similar Trials